> top > docs > PMC:7205724 > spans > 468-669 > annotations

PMC:7205724 / 468-669 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
11 31-39 Disease denotes COVID-19 MESH:C000657245
17 65-68 Gene denotes IL6 Gene:3569
18 124-127 Gene denotes IL6 Gene:3569
19 92-100 Species denotes patients Tax:9606
20 44-55 Chemical denotes Tocilizumab MESH:C502936
21 106-114 Disease denotes COVID-19 MESH:C000657245
53 143-160 Species denotes novel coronavirus Tax:2697049
54 162-171 Species denotes SARS-CoV2 Tax:2697049

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 31-39 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 106-114 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 162-166 Disease denotes SARS http://purl.obolibrary.org/obo/MONDO_0005091

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 183-184 http://purl.obolibrary.org/obo/CLO_0001020 denotes a

LitCovid-sample-MedDRA

Id Subject Object Predicate Lexical cue meddra_id
T2 2-12 http://purl.bioontology.org/ontology/MEDDRA/10022891 denotes viral load http://purl.bioontology.org/ontology/MEDDRA/10062178

LitCovid-sample-PD-NCBITaxon

Id Subject Object Predicate Lexical cue ncbi_taxonomy_id
T4 31-39 Species denotes COVID-19 NCBItxid:2697049
T5 106-114 Species denotes COVID-19 NCBItxid:2697049
T6 162-171 Species denotes SARS-CoV2 NCBItxid:2697049

LitCovid-sample-sentences

Id Subject Object Predicate Lexical cue
T9 41-128 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 130-138 Sentence denotes Abstract

LitCovid-sample-Pubtator

Id Subject Object Predicate Lexical cue pubann:denotes
11 31-39 Disease denotes COVID-19 MESH:C000657245
20 44-55 Chemical denotes Tocilizumab MESH:C502936
17 65-68 Gene denotes IL6 Gene:3569
19 92-100 Species denotes patients Tax:9606
21 106-114 Disease denotes COVID-19 MESH:C000657245
18 124-127 Gene denotes IL6 Gene:3569
53 143-160 Species denotes novel coronavirus Tax:2697049
54 162-171 Species denotes SARS-CoV2 Tax:2697049

LitCovid-sample-UniProt

Id Subject Object Predicate Lexical cue uniprot_id
T45 65-68 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0
T89 124-127 Protein denotes IL6 https://www.uniprot.org/uniprot/Q9XT80|https://www.uniprot.org/uniprot/Q9UCU4|https://www.uniprot.org/uniprot/Q9UCU3|https://www.uniprot.org/uniprot/Q9UCU2|https://www.uniprot.org/uniprot/Q9MZR1|https://www.uniprot.org/uniprot/Q9MYZ7|https://www.uniprot.org/uniprot/Q95KN6|https://www.uniprot.org/uniprot/Q95181|https://www.uniprot.org/uniprot/Q90YI0|https://www.uniprot.org/uniprot/Q8MKH0|https://www.uniprot.org/uniprot/Q8BN26|https://www.uniprot.org/uniprot/Q865X6|https://www.uniprot.org/uniprot/Q865W7|https://www.uniprot.org/uniprot/Q6V919|https://www.uniprot.org/uniprot/Q6L6X6|https://www.uniprot.org/uniprot/Q5I6E3|https://www.uniprot.org/uniprot/Q3UCQ0|https://www.uniprot.org/uniprot/Q2MH06|https://www.uniprot.org/uniprot/Q28819|https://www.uniprot.org/uniprot/Q28747|https://www.uniprot.org/uniprot/Q28319|https://www.uniprot.org/uniprot/Q25BC2|https://www.uniprot.org/uniprot/Q0PW36|https://www.uniprot.org/uniprot/Q0GGL7|https://www.uniprot.org/uniprot/Q08DT2|https://www.uniprot.org/uniprot/P79341|https://www.uniprot.org/uniprot/P51494|https://www.uniprot.org/uniprot/P46650|https://www.uniprot.org/uniprot/P41693|https://www.uniprot.org/uniprot/P41683|https://www.uniprot.org/uniprot/P41323|https://www.uniprot.org/uniprot/P29455|https://www.uniprot.org/uniprot/P26893|https://www.uniprot.org/uniprot/P26892|https://www.uniprot.org/uniprot/P20607|https://www.uniprot.org/uniprot/P08505|https://www.uniprot.org/uniprot/P05231|https://www.uniprot.org/uniprot/O46568|https://www.uniprot.org/uniprot/O35736|https://www.uniprot.org/uniprot/O19007|https://www.uniprot.org/uniprot/B6CKP4|https://www.uniprot.org/uniprot/A9QWQ9|https://www.uniprot.org/uniprot/A3FBE9|https://www.uniprot.org/uniprot/A0S0B0

LitCovid-sample-Enju

Id Subject Object Predicate Lexical cue
T67 0-1 -COMMA- denotes ,
T68 2-7 JJ denotes viral
T69 8-12 NN denotes load
T70 12-13 -COMMA- denotes ,
T71 14-17 CC denotes and
T72 18-27 NN denotes prognosis
T73 28-30 IN denotes of
T74 31-39 NN denotes COVID-19
T75 41-42 IN denotes
T76 44-55 NNP denotes Tocilizumab
T77 55-56 -COMMA- denotes ,
T78 57-59 DT denotes an
T79 60-68 NN denotes anti-IL6
T80 68-69 -COMMA- denotes ,
T81 70-73 MD denotes can
T82 74-80 VB denotes confer
T83 81-88 NN denotes benefit
T84 89-91 IN denotes in
T85 92-100 NNS denotes patients
T86 101-105 IN denotes with
T87 106-114 NN denotes COVID-19
T88 115-118 CC denotes and
T89 119-123 JJ denotes high
T90 124-127 NN denotes IL6
T91 130-138 NN denotes Abstract
T92 139-142 DT denotes The
T93 143-148 JJ denotes novel
T94 149-160 NN denotes coronavirus
T95 160-161 -COMMA- denotes ,
T96 162-171 NN denotes SARS-CoV2
T97 171-172 -COMMA- denotes ,
T98 173-176 MD denotes can
T99 177-182 VB denotes cause
T100 183-184 DT denotes a
T101 185-196 RB denotes potentially
R62 T69 T67 arg2Of load,","
R63 T69 T68 arg1Of load,viral
R64 T71 T70 arg1Of and,","
R65 T67 T71 arg1Of ",",and
R66 T72 T71 arg2Of prognosis,and
R67 T72 T73 arg1Of prognosis,of
R68 T74 T73 arg2Of COVID-19,of
R69 T82 T75 arg1Of confer,•
R70 T76 T77 arg1Of Tocilizumab,","
R71 T79 T77 arg2Of anti-IL6,","
R72 T79 T78 arg1Of anti-IL6,an
R73 T82 T80 arg1Of confer,","
R74 T76 T81 arg1Of Tocilizumab,can
R75 T82 T81 arg2Of confer,can
R76 T76 T82 arg1Of Tocilizumab,confer
R77 T83 T82 arg2Of benefit,confer
R78 T82 T84 arg1Of confer,in
R79 T85 T84 arg2Of patients,in
R80 T85 T86 arg1Of patients,with
R81 T88 T86 arg2Of and,with
R82 T87 T88 arg1Of COVID-19,and
R83 T90 T88 arg2Of IL6,and
R84 T90 T89 arg1Of IL6,high
R85 T94 T92 arg1Of coronavirus,The
R86 T94 T93 arg1Of coronavirus,novel
R87 T94 T95 arg1Of coronavirus,","
R88 T96 T95 arg2Of SARS-CoV2,","
R89 T99 T97 arg1Of cause,","
R90 T94 T98 arg1Of coronavirus,can
R91 T99 T98 arg2Of cause,can
R92 T94 T99 arg1Of coronavirus,cause

LitCovid-sample-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T4 31-39 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 106-114 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T6 162-171 Disease denotes SARS-CoV2 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T9 41-128 Sentence denotes • Tocilizumab, an anti-IL6, can confer benefit in patients with COVID-19 and high IL6.
T10 130-138 Sentence denotes Abstract